B7-H3 promotes acute and chronic allograft rejection. - Wikidata - awgldk - TriplyDB

B7-H3 promotes acute and chronic allograft rejection.

B7-H3 promotes acute and chronic allograft rejection.

http://www.wikidata.org/entity/Q34389662

about

Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses Generation and characterization of B7-H4/B7S1/B7x-deficient mice Origination of new immunological functions in the costimulatory molecule B7-H3: the role of exon duplication in evolution of the immune system Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer B7-h3 and its role in antitumor immunity B7-H3 expression in breast cancer and upregulation of VEGF through gene silence Characterization of a soluble B7-H3 (sB7-H3) spliced from the intron and analysis of sB7-H3 in the sera of patients with hepatocellular carcinoma.B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell Subsets.Pancreatic ductal adenocarcinoma: a review of immunologic aspects.The role of coinhibitory signaling pathways in transplantation and tolerance Advances in understanding the pathogenesis of graft-versus-host disease.Tissue biomarkers for prostate cancer radiation therapy.Co-stimulatory molecules as potential targets for therapeutic intervention in allergic airway disease.Modulation of immune response by B7 family molecules in tumor microenvironments.Costimulation blockade and its possible future use in clinical transplantation.The contrasting role of B7-H3.From cancer immunosurveillance to cancer immunotherapy.Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.Fine tuning the immune response through B7-H3 and B7-H4 Intact B7-H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responses Senescence-associated exosome release from human prostate cancer cells.Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance.Clinical importance of B7-H3 expression in human pancreatic cancer.Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection.The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy.Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function.The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy.Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications.Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum.4IgB7-H3 is the major isoform expressed on immunocytes as well as malignant cells.Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.Upregulation of the B7/CD28 family member B7-H3 in bladder cancer.B7-H3 in tumors: friend or foe for tumor immunity?B7-H3 was highly expressed in human primary hepatocellular carcinoma and promoted tumor progression.Perspectives of Immune Suppression in the Tumor Microenvironment Promoting Oral Malignancy.

P2860

Q24316331-DAEC13CE-15F6-4876-845C-D476AF37F121 Q28585447-045B9921-4EAC-4DFF-9F50-785AB317BA66 Q28740426-E668C5DF-8FB4-4605-A65A-AB1862310088 Q33520828-8C507CA1-707B-41E7-B8BB-E8D16A7B79A2 Q34356712-95C23F0A-A3B5-4366-907B-306519A8C625 Q34446315-6801A7E5-040A-4392-BF09-EA7BBAE3CF3F Q35032331-1F67627B-FA54-46BA-B2B8-5831E6846E24 Q35634896-0AA983D3-548C-4632-8823-F689603FC1D1 Q35660891-CB3AA291-F44F-414F-848D-6F8BDEE391CA Q35870682-E42AA858-A120-4A00-98F7-2A50D5D7637D Q35928357-112DFB0D-6D5E-451A-BACD-95AF9FDE3BA9 Q35971439-A2FAC9DD-936D-466A-83BD-E6C47DC7611E Q36141341-0EB54F7C-ABEE-40F5-B559-5DF3A351D9A5 Q36360561-326943A7-13E1-4F11-B428-6CA8DB322F5F Q36569007-797BC7FE-EF28-4A53-81CA-8E8336FB51AC Q36570561-CF5E61E1-D94A-4318-AA25-7CDF018A0BA2 Q36802534-C49AE501-824F-4170-9BCF-DFB34961F16A Q36990588-99C144CA-42E3-4C47-99AC-E661F8EA1D8B Q36998864-F498D103-BCED-4504-B86B-3B043AF87412 Q37227080-5D956A65-FDA8-41CC-9CC0-8D5C7D598A30 Q37292542-162ACA8C-6DE3-48E1-9F6F-A0906E69FCEA Q37352797-41B0B899-CB05-4F6D-B533-10DAFBE1FFC2 Q37378417-1215286B-CED8-49DC-84DF-5A465A48ACF2 Q37424100-535798BA-DF93-485A-ADAB-8E653C28EC80 Q37656365-99948368-2B2B-4F2E-B6E9-8E33FB3EC877 Q38304438-277B8CB0-2934-4BDB-8322-6147DDC359D6 Q38619142-3A1B5178-6059-4F80-A3CF-23A4645C22AA Q39160982-386B8C28-3B45-4195-AD24-3041FFBF86AC Q39161011-AECA153D-E8C5-42F9-A32B-2E6496A920CE Q39181190-549C0902-8F80-43EA-A0A1-DB151EBD41E6 Q39500230-728B4494-BF78-44B6-A6BE-35FDD2042A91 Q39742066-95B5D268-17F3-402C-9FBF-F535ECFCAE0E Q40025345-A6E4A7BB-105E-4254-B86D-0570EB23EFBA Q40111697-49D24455-84CB-4A62-879A-B0D0695F23F1 Q41809391-A6FBEEE9-0638-4575-AA55-3A16E8108EC6 Q41851335-A2317098-B8D3-4B8F-9574-A68E641C1D28 Q47233613-0751F8A2-DD3D-437A-A7DE-4BBA1F4A58BA Q53238384-A00F82F8-0B7F-40B8-8192-E70CE4174644 Q55511990-D691228C-F6E7-4070-B3E9-B2EB159BCB8B

P2860

B7-H3 promotes acute and chronic allograft rejection.

http://www.wikidata.org/entity/Q34389662

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

B7-H3 promotes acute and chronic allograft rejection.

@ast

B7-H3 promotes acute and chronic allograft rejection.

@en

B7-H3 promotes acute and chronic allograft rejection.

@nl

type

label

B7-H3 promotes acute and chronic allograft rejection.

@ast

B7-H3 promotes acute and chronic allograft rejection.

@en

B7-H3 promotes acute and chronic allograft rejection.

@nl

prefLabel

B7-H3 promotes acute and chronic allograft rejection.

@ast

B7-H3 promotes acute and chronic allograft rejection.

@en

B7-H3 promotes acute and chronic allograft rejection.

@nl

P1433

Q34389662-7F419C37-72CD-441A-9BC2-F8D9F2A2E23A

P1476

Q34389662-424C242F-C57B-4227-8FBA-3A2DD657628E

P2093

Q34389662-21E75DB2-1C50-4648-A2A9-0491145074DA

Q34389662-28D05739-1C34-4B04-B322-B20F18CB0BD7

Q34389662-2BD4AA22-C2D8-4FD3-A3A4-C22FCB7656B6

Q34389662-633E6936-FA5C-411E-A84E-D104B304A526

Q34389662-8BD6B51D-44B6-47C5-88D8-30EA3C81E470

Q34389662-98B167C0-D2CF-4B0C-9B22-163A413086B5

Q34389662-A7291A7A-2621-485A-9D72-68FAD06811B5

Q34389662-A9A4D159-16C9-4BBE-9319-A01CA13033A0

P2860

Q34389662-01B5D819-4097-47CB-A097-3450038E4C72

Q34389662-2581BD43-83F7-436E-8C69-3849E8F318B3

Q34389662-3E554CFC-9962-4A57-BA6F-BC3749D52B9D

Q34389662-4B3BD995-3083-40B1-9249-102BE51377BE

Q34389662-4CA19AE5-A293-4100-861A-3990A1681935

Q34389662-6694F352-EE8A-4960-9398-14A70F816EFD

Q34389662-7A87F221-64A8-4D5B-A303-2E2794E23DF3

Q34389662-96C81732-6A13-43BB-BA05-E284BBA551D0

Q34389662-E44CA2C6-F4D5-4B65-8ADB-58A055127CA0

P304

Q34389662-AEEEE64C-C14A-4DB2-A0CD-223CAA27E3C8

P31

Q34389662-BB89372D-2E45-4910-B061-26682E16F00B

P356

Q34389662-4D9EF394-3C99-49B9-9DA1-362FFE8B0C4F

P407

Q34389662-9AA6B466-6458-4D2A-8F67-C60492F29B50

P433

Q34389662-653E7946-1DAE-449B-9CE7-C432FB7188E9

P478

Q34389662-0BFACF1E-7E31-4CE6-B9AD-F2E9BA4B63CE

P577

Q34389662-40968C44-49D3-49FB-83A6-92873CE86924

P5875

Q34389662-306B565E-776C-4B62-BEDC-9CF0C1FFD48E

P698

Q34389662-A284A24C-06C9-43B2-9D73-3408BB22E494

P356

P1433

European Journal of Immunology

P1476

B7-H3 promotes acute and chronic allograft rejection.

@en

P2093

Andrew D Wells

http://www.w3.org/2001/XMLSchema#string

Anthony J Coyle

http://www.w3.org/2001/XMLSchema#string

Christopher C Fraser

http://www.w3.org/2001/XMLSchema#string

Kristine Kikly

http://www.w3.org/2001/XMLSchema#string

Lieping Chen

http://www.w3.org/2001/XMLSchema#string

Liqing Wang

http://www.w3.org/2001/XMLSchema#string

Rongxiang Han

http://www.w3.org/2001/XMLSchema#string

Wayne W Hancock

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of mouse and human B7-H3 genes

Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism

Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains.

Survival of cardiac xenografts. Effect of antithymocyte serum and enhancing heteroantiserum.

B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells.

Programmed death-1 targeting can promote allograft survival.

Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection.

Functional responses and costimulator dependence of memory CD4+ T cells.

CD28-independent costimulation of T cells in alloimmune responses.

P304

428-438

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EJI.200425518

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8050630

http://www.w3.org/2001/XMLSchema#string

P698

15682454

http://www.w3.org/2001/XMLSchema#string